![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
Drug Development Costs (Patent Baristas)
In his entry, Stephen Albainy-Jenei discusses a study released last week by the Tufts Center for the Study of Drug Development saying that that the average cost of developing a new biotechnology product is $1.2 billion.
Similarly, another study shows that "the cost per patient of running Phase III clinical studies of new pharmaceuticals now exceeds $26,000, on average, according to a report, 'Clinical Operations: Accelerating Trials, Allocating Resources and Measuring Performance,' published by Cutting Edge Information," he points out.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct